Structural heart disease treatment devices are repair and replacement devices used for the treatment of structural heart diseases that could lead to a heart attack, or any other issue occurring in the valves or vessels of the heart.
Due to the COVID-19 pandemic, the global Structural Heart Disease Treatment Devices market size is estimated to be worth US$ 13790 million in 2021 and is forecast to a readjusted size of US$ 22330 million by 2028 with a CAGR of 7.0% during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Structural Heart Disease Treatment Devices market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Structural Heart Disease Treatment Devices landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
North Americas accounted for the maximum growth of the cardiovascular devices market during 2017. With the growing preference for tissue heart valves over mechanical heart valves and the increased popularity of MI and transcatheter procedures in the developed economies such as the US, this region will account for the maximum growth of this market during the next few years as well.
This report focuses on Structural Heart Disease Treatment Devices volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Structural Heart Disease Treatment Devices market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Global Structural Heart Disease Treatment Devices Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Repair Devices
Replacement Devices
Segment by Application
Hospitals
Ambulatory Surgery Centers
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Abbott
Boston Scientific
Edwards Lifesciences
LivaNova
Lepu Medical Technology
Medtronic